FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 7.841
EU - Europa 3.228
AS - Asia 1.179
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
AF - Africa 5
Totale 12.292
Nazione #
US - Stati Uniti d'America 7.807
GB - Regno Unito 1.194
IT - Italia 576
SE - Svezia 514
CN - Cina 400
SG - Singapore 297
DE - Germania 279
HK - Hong Kong 205
UA - Ucraina 166
FI - Finlandia 149
TR - Turchia 119
FR - Francia 102
BG - Bulgaria 68
IN - India 54
BE - Belgio 39
CZ - Repubblica Ceca 33
CA - Canada 21
ID - Indonesia 20
VN - Vietnam 20
IE - Irlanda 16
LT - Lituania 16
KR - Corea 15
IR - Iran 14
BZ - Belize 13
EU - Europa 12
JP - Giappone 12
NL - Olanda 12
RU - Federazione Russa 12
BR - Brasile 7
ES - Italia 7
AU - Australia 6
CH - Svizzera 6
MY - Malesia 6
PL - Polonia 6
AT - Austria 5
DK - Danimarca 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
PE - Perù 4
TW - Taiwan 4
BD - Bangladesh 3
CL - Cile 3
GR - Grecia 3
CO - Colombia 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
MZ - Mozambico 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 12.292
Città #
Fairfield 1.188
Southend 978
Woodbridge 746
Ashburn 679
Chandler 591
Houston 558
Ann Arbor 455
Seattle 443
Cambridge 357
Wilmington 335
Nyköping 331
Jacksonville 328
Santa Clara 328
Dearborn 317
Singapore 211
Hong Kong 198
Modena 184
New York 110
Beijing 101
Helsinki 90
San Diego 80
Fremont 73
Bremen 67
Sofia 67
Princeton 66
Eugene 63
Izmir 63
Bologna 44
London 35
Redwood City 34
Brussels 32
Boardman 28
Shanghai 28
Milan 25
Munich 25
Des Moines 24
Jakarta 19
San Jose 19
Dallas 17
Chicago 16
Dong Ket 16
Las Vegas 16
Dublin 15
Hefei 14
Toronto 14
Albuquerque 13
Belize City 13
Brno 12
Kunming 12
Guangzhou 11
Leawood 10
Washington 10
Kilburn 9
Nanjing 9
Paris 9
Pavia 9
Rome 9
Chiswick 8
Norwalk 8
San Mateo 8
Wuhan 8
Perugia 7
Saint Louis 7
San Francisco 7
Seongnam-si 7
Botucatu 6
Nanchang 6
Rimini 6
Romainville 6
Bangalore 5
Bengaluru 5
Correggio 5
Parma 5
Phoenix 5
Prescot 5
Tokyo 5
Tulare 5
Verona 5
Bari 4
Castelnuovo Rangone 4
Central 4
Chengdu 4
Columbus 4
Falls Church 4
Genova 4
Ghent 4
Grafing 4
Hanoi 4
Kosice 4
Los Angeles 4
Philadelphia 4
San Giuliano Milanese 4
Vienna 4
Amsterdam 3
Asti 3
Atlanta 3
Bristol 3
Changsha 3
Chimbote 3
Cresserons 3
Totale 9.764
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 288
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 267
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 254
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 249
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 247
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 245
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 242
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 229
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 228
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 223
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 221
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 216
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 214
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 212
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 211
Mucorales-specific T cells in patients with hematologic malignancies 208
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 208
Acute appendicitis in adult neutropenic patients with hematologic malignancies 207
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 205
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 205
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 205
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 204
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 202
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 202
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 202
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 202
B cells and herpesviruses: a model of lymphoproliferation 201
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 200
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 197
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 197
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 196
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 195
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 188
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 186
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 186
How I treat HHV8/KSHV-related diseases in posttransplant patients. 182
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 180
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 179
Pain and emotional distress in leukemia patients at diagnosis. 178
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 175
Inflammatory myofibroblastic tumor of the bone marrow. 175
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 175
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 175
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 172
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 167
Philadelphia chromosome-positive acute lymphoblastic leukemia 167
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 166
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 165
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 165
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 158
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 157
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 155
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 154
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 153
Splenomegaly in hematological malignancies and portal hypertension 152
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 151
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 149
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 149
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 143
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 140
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 139
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 136
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 134
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 125
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 121
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 62
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 48
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 38
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 35
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 26
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 18
Totale 12.506
Categoria #
all - tutte 48.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.128 0 0 0 0 290 410 500 349 250 101 111 117
2020/20212.173 142 132 183 268 231 185 141 251 99 261 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/2025804 129 44 72 214 345 0 0 0 0 0 0 0
Totale 12.506